Error: Could not add to watchlist. X

Salix Pharmaceuticals Ltd

+ Watchlist
SLXP:US
Acquired
SLXP:US was acquired by VRX:CN
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.60
Market Cap (USD)
-
Shares Outstanding (m)
64.249
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.
ADDRESS
8510 Colonnade Center Drive
Raleigh, NC 27615
United States
PHONE
1-919-862-1000
Show More